| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |